Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enveric Biosciences Inc (NQ: ENVB ) 0.4292 +0.0080 (+1.90%) Streaming Delayed Price Updated: 3:55 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Enveric Biosciences Inc < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday August 04, 2022 Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session August 03, 2022 Gainers Via Benzinga Enveric Biosciences Appoints New Independent Directors July 27, 2022 From Enveric Biosciences, Inc. Via Business Wire Enveric Biosciences Announces Closing of $8 Million Registered Direct and Private Placement Offerings, Priced at a Premium to Market Under Nasdaq Rules July 26, 2022 From Enveric Biosciences, Inc. Via Business Wire Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday July 26, 2022 Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday. Via Benzinga Nasdaq Drops 100 Points; Crude Oil Rises Sharply July 25, 2022 U.S. stocks traded mostly lower toward the end of trading on Monday. Via Benzinga Dow Rises Over 100 Points; Revelation Biosciences Shares Spike Higher July 25, 2022 U.S. stocks traded mostly higher midway through trading on Monday. Via Benzinga Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session July 25, 2022 Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis. Via Benzinga Why U.S. Stocks Are Trading Mostly Higher; Chicago Fed National Activity Index Remains Unchanged July 25, 2022 U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 100 points on Monday. Via Benzinga Enveric Biosciences Stock Is Nosediving Today: What's Happening? July 25, 2022 Enveric Biosciences Inc (NASDAQ: ENVB) shares are trading lower by 21.84% to $7.55 Monday morning after the company announced an $8 million registered direct offering and private placement. Via Benzinga Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact July 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 11 Health Care Stocks Moving In Monday's Pre-Market Session July 25, 2022 Via Benzinga Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules July 25, 2022 From Enveric Biosciences, Inc. Via Business Wire This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday July 25, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session July 22, 2022 Via Benzinga Enveric Biosciences Announces Formation of Scientific Advisory Board to Drive Further Growth of Next-Generation Mental Health Medicines July 19, 2022 From Enveric Biosciences, Inc. Via Business Wire The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate July 15, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session July 14, 2022 Via Benzinga Enveric Biosciences Announces Reverse Stock Split July 14, 2022 From Enveric Biosciences, Inc. Via Business Wire Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday July 15, 2022 Gainers Via Benzinga Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market July 13, 2022 Article by Jason Najum. Psychedelic startups face a more challenging time raising capital amid market volatility, the prospect of rate hikes, and recession fears, but that could ultimately help the... Via Benzinga Enveric Biosciences Advances Drug Development for Mental Health Indications and Intellectual Property Portfolio July 13, 2022 From Enveric Biosciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's Intraday Session July 12, 2022 Via Benzinga Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session July 11, 2022 Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session July 11, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session June 30, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 28, 2022 Via Benzinga 10 Psychedelics CEOs To Pay Attention To In 2022 June 22, 2022 By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both... Via Benzinga This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday June 30, 2022 Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022 June 01, 2022 Upgrades Via Benzinga < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.